Skip to main content
Signal8

Journey Medical Corp (DERM)

Journey Medical Corporation, a pharmaceutical firm established in Scottsdale, Arizona in 2014 (and previously known as Coronado Dermatology, Inc.), is dedicated to the development and market introduction of treatments for skin conditions across the United States. Their product line encompasses key dermatological therapies such as Qbrexza, a medicated cloth wipe for managing primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe, persistent acne; Targadox, an oral doxycycline medication used as an additional treatment for severe acne; Ximino, an oral minocycline drug addressing moderate to severe acne; and Exelderm, offered as a topical cream and solution. Furthermore, the company distributes doxycycline hyclate tablets, minocycline hydrochloride capsules, and sulconazole nitrate cream and solution.

Sector: Pharmaceutical Preparations

Industry: Drug Manufacturers - Specialty & Generic

Journey Medical Corporation logo

Journey Medical Corporation

NASDAQ:DERMHealthcare
-1.00%$4.97
AH Close$4.96-0.12%vs close
Mkt Cap$140.28M
Float12.04M
O/S28.22M
Inst Own36.2%
SI25.4%
Dilution
Journey Medical Corporation logoNASDAQ:DERM$4.97-1.00%
Delisting Issues Timeline
Financials Summary
Revenue$61.86M
Net Income-$11.43M
Total Assets$94.59M
Free Cash Flow-$12.44M
Debt & Equity
Debt 44%
Equity 56%
Total Debt$25.4M
Total Equity$31.85M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in DERM's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$94.59M
Liabilities$62.74M
Accounts Receivable$29.78M
Accounts Payable$9.31M
Inventory$9.62M
PP&E (Net)$111K
Goodwill$0
Intangible Assets$27.61M
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Revenue$61.86M$56.13M$79.18M$73.67M$63.13M$44.53M$34.92M$42.34M$4.54M$22.59M$7.3M$7.3M
YoY Growth10.2%-29.1%7.5%16.7%41.8%27.5%-17.5%832.4%-79.9%209.4%0.0%-
Cost of Revenue$25.18M$20.88M$26.66M$30.77M$32.08M$14.59M$10.53M$1.18M$0$0$0$0
Gross Profit$36.68M$35.26M$52.52M$42.89M$31.05M$29.94M$24.39M$41.16M$4.54M$22.59M$7.3M$7.3M
Gross Margin59.3%62.8%66.3%58.2%49.2%67.2%69.8%97.2%100.0%100.0%100.0%100.0%
Research and Development$480K$9.86M$7.54M$10.94M$16.56M$0$0$80.55M$104.41M$83.17M$66.83M$30.71M
Selling, General, and Administrative$44.37M$40.2M$43.91M$59.47M$39.83M$0$19.13M$172.58M$71.9M$30.04M$17.72M$8.29M
Other$0-$1.13M$3.14M$0$9.54M$22.09M$0$2.02M$128.56M$0$2.52M$0
Total Operating Expenses$44.85M$48.93M$54.59M$70.41M$65.93M$22.09M$19.13M$255.15M$304.87M$113.21M$87.07M$39M
Operating Income (EBIT)-$8.17M-$13.68M-$2.07M-$27.52M-$34.88M$7.85M$5.26M-$213.98M-$300.33M-$90.62M-$79.77M-$31.7M
Operating Margin-13.2%-24.4%-2.6%-37.4%-55.2%17.6%15.1%-505.4%-6613.7%-401.3%-1092.7%-434.2%
Interest Expense$3.7M$2.7M$1.7M$2.02M$7.03M$698K$255K$15.64M$8.14M$1.54M$147K$153K
Interest Income$589K$757K$322K$60K$2K$0$0$0$0$0$0$0
Other Income (Expense)-$3.2M-$934K-$1.56M-$2.05M-$7.48M-$698K-$255K-$7.75M-$2.94M$1.54M$749K-$146K
Income Before Tax (EBT)-$11.37M-$14.61M-$3.63M-$29.57M-$42.36M$7.15M$5M-$221.73M-$303.26M-$89.08M-$79.02M-$31.84M
Income Tax Expense$60K$61K$221K$63K$1.63M$1.87M$1.38M-$194K$0$0-$622K$31K
Net Income-$11.43M-$14.67M-$3.85M-$29.63M-$43.99M$5.28M$3.63M-$221.54M-$303.26M-$89.08M-$78.4M-$31.88M
Net Income Margin-18.5%-26.1%-4.9%-40.2%-69.7%11.9%10.4%-523.3%-6678.3%-394.4%-1074.0%-436.6%
Supplementary Data
EPS-0.47-0.72-0.21-1.69-2.540.320.22-5.27-7.48-2.70-2.93-1.29
Diluted EPS-0.47-0.72-0.21-1.69-2.540.320.22-5.27-7.48-2.70-2.93-1.29
Weighted Average OS24.50M20.43M18.23M17.53M17.32M16.66M16.66M42.00M40.56M33.04M26.73M24.66M
EBITDA-$3.33M-$8.4M$1.92M-$23.18M-$32.77M$9.37M$6.52M-$205.54M-$294.78M-$87.42M-$78.8M-$31.64M
EBITDA Margin-5.4%-15.0%2.4%-31.5%-51.9%21.0%18.7%-485.5%-6491.6%-387.1%-1079.5%-433.5%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Assets
Current Assets
Cash and Cash Equivalents$24.09M$20.3M$27.44M$32M$49.08M$8.25M$4.8M$104.98M$295.92M$41.79M$107.24M$55.36M
Short-Term Investments$0$0$0$0$0$0$0$208.06M$255.07M$210.15M$107.45M$41.79M
Cash and Short-Term Investments$24.09M$20.3M$27.44M$32M$49.08M$8.25M$4.8M$313.04M$550.99M$251.94M$214.69M$97.15M
Accounts Receivable$29.78M$10.23M$15.22M$28.21M$23.11M$23.93M$18.95M$5.72M$52K$21.4M$0$7.3M
Inventory$9.62M$14.43M$10.21M$14.16M$9.86M$1.4M$857K$8.37M$0$0$0$0
Other Current Assets$3.38M$3.21M$3.59M$3.31M$0$0$0$8.28M$5.57M$10.65M$2.54M$1.01M
Total Current Assets$66.87M$48.18M$56.45M$77.68M$84.49M$35.24M$25.27M$335.41M$556.61M$283.99M$217.23M$105.46M
Long-Term Assets
Property, Plant & Equipment Net$111K$199K$101K$189K$89K$175K$89K$1.18M$1.43M$1.13M$386K$192K
Goodwill$0$0$0$0$0$0$0$771K$771K$771K$771K$771K
Intangible Assets$27.61M$31.86M$20.29M$27.2M$12.55M$15.03M$7.38M$952K$1.13M$1.13M$1.13M$3.52M
Long-Term Investments$0$0$0$0$0$0$0$2.96M$0$24.55M$1.02M$66.48M
Deferred Tax Assets$0$0$0$0$0$1.45M$1.12M$0$194K$194K$194K$816K
Other Long-Term Assets$0$0$6K$95K$150K$6K$6K$3.05M$656K$841K$1.2M$976K
Total Long-Term Assets$27.72M$32.06M$20.39M$27.48M$12.79M$16.66M$8.59M$8.91M$4.18M$28.61M$4.7M$72.76M
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$94.59M$80.24M$76.85M$105.16M$97.28M$51.91M$33.86M$344.32M$560.79M$312.6M$221.93M$178.22M
Liabilities
Current Liabilities
Accounts Payable$9.31M$16.05M$16.08M$36.98M$22.81M$1.96M$2.11M$15.95M$15.09M$13.5M$9.23M$5.56M
Short-Term Debt$0$625K$3M$2.95M$5.32M$4.52M$0$0$4.63M$3.02M$1.07M$0
Current Income Tax Payable$70K$60K$53K$35K$8K$0$0$3.19M$4.63M$3.02M$1.07M$635K
Current Unearned Revenue$0$0$53K$0$0$0$0$0$4.99M$4.26M$10M$10M
Other Current Liabilities$9.57M$14.45M$4.08M$14.1M$20.08M$2.58M$7.09M$22.61M$80.65M$14.21M$5.59M-$3.67M
Total Current Liabilities$37.44M$35.17M$41.87M$66.83M$51.61M$28.06M$20.9M$38.56M$105.36M$34.99M$25.9M$11.89M
Long-Term Liabilities
Long-Term Debt$25.28M$24.88M$14.62M$19.83M$3.63M$5.22M$5.22M$313.79M$279.39M$0$0$1.94M
Long-Term Unearned Revenue$0$0$0$0$0-$99K$0$0$25.29M$29.55M$10M$10M
Long-Term Deferred Tax Liabilities$0$0$0$0$8K$99K$0$0$194K$194K$194K$816K
Other Long-Term Liabilities$0$0$0$1.41M$0$8.24M$4.99M$1.01M$918K$495K$367K$0
Total Long-Term Liabilities$25.3M$25M$14.63M$21.35M$3.63M$13.55M$10.21M$314.8M$305.79M$30.24M$10.56M$12.75M
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$62.74M$60.17M$56.5M$88.18M$55.24M$41.61M$31.11M$353.36M$411.14M$65.23M$36.46M$24.64M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$178.22M
Common Stock$2K$2K$2K$2K$2K$1K$1K$42K$42K$36K$30K$25K
Retained Earnings-$98.46M-$87.03M-$72.36M-$68.5M-$38.87M$5.12M-$163K-$745.04M-$553.39M-$250.13M-$161.05M-$82.65M
Comprehensive Income & Other$0$0$0$0$0$0$0-$1.02M-$511K-$198K-$75K-$16K
Other Stockholders' Equity$130.31M$107.09M$92.7M$85.48M$80.92M$5.17M$2.91M$735.96M$703M$497.47M$346.49M$236.2M
Total Equity$31.85M$20.07M$20.35M$16.98M$42.04M$10.29M$2.75M-$9.04M$149.65M$247.37M$185.47M$153.58M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$94.59M$80.24M$76.85M$105.16M$97.28M$51.91M$33.86M$344.32M$560.79M$312.6M$221.93M$178.22M
Supplementary Data
Total Debt$25.4M$25.7M$17.73M$22.96M$9.05M$9.92M$5.3M$313.79M$279.39M$0$0$1.94M
Net Debt$1.31M$5.4M-$9.71M-$9.04M-$40.03M$1.68M$502K$208.81M-$16.53M-$41.79M-$107.24M-$53.42M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Operating Activities
Net Income-$11.43M-$14.67M-$3.85M-$29.63M-$43.99M$5.28M$3.63M-$221.54M-$303.26M-$89.08M-$78.4M-$31.88M
Depreciation & Amortization$4.35M$3.52M$3.85M$4.37M$2.56M$1.52M$1.26M$555K$339K$123K$72K$47K
Deferred Income Tax$0$0$0$0$1.57M-$335K$69K-$194K$0-$622K$31K$31K
Stock-Based Compensation$6.29M$6.1M$2.61M$4.42M$2.47M$153K$240K$29.84M$20.7M$0$5.13M$1.64M
Changes in Working Capital:
  Accounts Receivable-$19.34M$4.47M$12.55M-$5.38M$768K-$5.02M-$10.49M-$5.67M$21.35M-$21.4M$7.3M-$7.3M
  Inventory$4.81M-$4.22M$3.95M$1.74M-$8.46M-$547K-$179K-$8.37M-$271.89M-$174.2M-$104.48M-$91.02M
  Accounts Payable-$7.2M-$2.1M-$18.42M$14.34M$20.39M-$152K$1.15M$823K$1.54M$4.27M$3.61M$3.21M
  Other Working Capital$9.83M-$1.92M$262K-$4.52M$2.01M$3.49M$12.99M-$141.18M$451.26M$249M$191.34M$93.57M
Total Working Capital Change-$11.9M-$3.77M-$1.66M$6.19M$14.71M-$2.23M$3.46M-$154.4M$202.26M$57.66M$97.76M-$1.54M
Other Non-Cash Items$255K-$302K$4.29M$1.12M$20.51M$747K$355K$132.64M-$24M-$42.19M-$73.04M$292K
Net Cash from Operating-$12.44M-$9.13M$5.24M-$13.53M-$2.18M$5.13M$9.02M-$213.1M-$103.96M-$74.11M-$48.44M-$31.4M
Investing Activities
Capital Expenditures$0-$15M-$5M-$20M-$10M-$1.2M-$2.4M-$616K-$278K-$753K-$202K-$156K
Acquisitions$0$0$0$0$0$0$0$0$0$130.29M$0$0
Purchases of Investments$0$0$0$0$0$0$0-$319.94M-$302.43M-$252.18M-$60.28M-$109.32M
Sales of Investments$0$0$0$0$0$0$0$363.33M$278.58M$122.64M$57.88M$0
Other Investing Activities$0$0$0$0$0$0$0-$56M-$80.3M-$130.29M$0$0
Net Cash from Investing$0-$15M-$5M-$20M-$10M-$1.2M-$2.4M-$13.23M-$104.43M-$130.29M-$2.6M-$109.48M
Financing Activities
Debt Repaid-$15.73M-$16.63M$1.51M-$14.76M-$4.24M$500K$3.55M-----
Common Stock Issuance$567K$416K$4.62M$142K$32.54M$0$0$2.15M$181.54M$138.95M$105.05M$116.26M
Common Stock Repurchases$0$0$0$0$0$0$0$2.15M$184.28M$138.95M$105.05M$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities-$75K-$50K-$4.96M-$585K-$3.55M$13K$0$35.38M$462.52M$138.95M$102.93M-$3.49M
Net Cash from Financing$16.23M$16.99M-$4.8M$16.46M$53.02M-$487K-$3.55M$35.38M$462.52M$138.95M$102.93M$174.1M
Forex Effect$0$0$0$0$0$0$0$0$0$0$0-$22.14M
Net Change in Cash$3.79M-$7.13M-$4.56M-$17.08M$40.84M$3.44M$3.07M-$190.94M$254.13M-$65.45M$51.88M$11.07M
Supplementary Data
Operating Cash Flow-$12.44M-$9.13M$5.24M-$13.53M-$2.18M$5.13M$9.02M-$213.1M-$103.96M-$74.11M-$48.44M-$31.4M
Capital Expenditure$0-$15M-$5M-$20M-$10M-$1.2M-$2.4M-$616K-$278K-$753K-$202K-$156K
Free Cash Flow-$12.44M-$24.13M$240K-$33.53M-$12.18M$3.93M$6.62M-$213.71M-$104.24M-$74.86M-$48.64M-$31.56M
Cash at Beginning$20.3M$27.44M$32M$49.08M$8.25M$4.8M$1.73M$295.92M$41.79M$107.24M$55.36M$22.14M
Cash at End$24.09M$20.3M$27.44M$32M$49.08M$8.25M$4.8M$104.98M$295.92M$41.79M$107.24M$33.21M